Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027?
Health & MedicineOne-Off3Mon
Manifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-Prognose
Nein 56.3%
Prognostiker
17
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 16 Stunden
Veraltet5. Okt. 24, 02:42 UTC2. Jan. 27, 04:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Will the FDA approve any psychedelic substance for medical use this year?
Kalshi[ACX 2026] Will the US, UK or EU approve a gene editing therapy for a new condition during 2026?
Manifold MarketsWhen will the FDA approve Compass Pathways' COMP360 Psilocybin?
Kalshi[ACX 2026] Will the FDA approve a psilocybin treatment during 2026?
Manifold MarketsWill the FDA approve MDMA for PTSD?
KalshiWill the FDA approve a psilocybin treatment during 2026?
FutuurRegeln
https://www.science.org/content/article/fda-rejected-mdma-assisted-ptsd-therapy-other-psychedelics-firms-intend-avoid-fate
- Resolves YES if any currently known psychedelic substance (as of October 4th, 2024) is FDA approved for any category of mental disorder by January 1st 2027.
- The caveat is mainly to avoid the possibility that any subsequent drug development produces a treatment for a mental disorder that is later found out to have psychedelic effects.
- Possible clarification from creator (AI generated): Market will resolve as N/A if the FDA is abolished before January 1st 2027.
Offene Märkte
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Gesamtvolumen
- 15,6 Mio. €
- 24h-Volumen
- 18.288,2 €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Gesamtvolumen
- 1,6 Mio. €
- 24h-Volumen
- 5178,9 €
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+64.0pt98%
- before 2027+22.0pt98%
- before December+30.0pt98%
+3 weitere Ergebnisse
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt65%
- September+2.0pt41%
- June28%
- Gesamtvolumen
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Gesamtvolumen
- 916.002,6 €
- 24h-Volumen
- 1515,1 €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-2.0pt57%
+2 weitere Ergebnisse
- Gesamtvolumen
- 863.640,2 €
- 24h-Volumen
- 1039 €
- Ebola pandemic in 2026?
- Will 3 mg THC beverages be federally legal to sell?
- Ebola pandemic in 2026?
- Measles cases in U.S. in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Will the FDA approve CagriSema?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
Häufige Fragen
- Wie stehen die aktuellen Quoten für Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027??
- Manifold Markets bewertet No mit 56% (Stand: 8. September 2026).
- Wann wird Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027? entschieden?
- Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027? soll am 2. Januar 2027 entschieden werden.
- Wie wird Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027? abgerechnet?
- Manifold Markets rechnet diesen Markt wie folgt ab: https://www.science.org/content/article/fda-rejected-mdma-assisted-ptsd-therapy-other-psychedelics-firms-intend-avoid-fate